Volume | 54,408 |
|
|||||
News | - | ||||||
Day High | 1.50 | Low High |
|||||
Day Low | 1.44 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Enlivex Therapeutics Ltd | ENLV | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.47 | 1.44 | 1.50 | 1.45 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
337 | 54,408 | $ 1.46 | $ 79,485 | - | 1.15 - 4.59 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:54:46 | 1 | $ 1.445 | USD |
Enlivex Therapeutics Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
27.26M | 18.42M | - | 0 | -31.06M | -1.69 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Enlivex Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ENLV Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.36 | 1.53 | 1.2301 | 1.39 | 77,195 | 0.09 | 6.62% |
1 Month | 3.75 | 4.59 | 1.15 | 2.02 | 370,585 | -2.30 | -61.33% |
3 Months | 2.75 | 4.59 | 1.15 | 2.50 | 177,923 | -1.30 | -47.27% |
6 Months | 1.27 | 4.59 | 1.15 | 2.55 | 128,426 | 0.18 | 14.17% |
1 Year | 2.83 | 4.59 | 1.15 | 2.51 | 76,152 | -1.38 | -48.76% |
3 Years | 10.20 | 13.95 | 1.15 | 6.80 | 86,423 | -8.75 | -85.78% |
5 Years | 8.71 | 44.90 | 1.15 | 9.86 | 162,142 | -7.26 | -83.35% |
Enlivex Therapeutics Description
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms. |